Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003924
Filing Date
2019-05-03
Accepted
2019-05-03 10:02:11
Documents
52
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20190331x10q.htm 10-Q 1628964
2 EX-31.1 rytm-20190331ex311bbbb79.htm EX-31.1 16322
3 EX-31.2 rytm-20190331ex31213c028.htm EX-31.2 15664
4 EX-32.1 rytm-20190331ex3216033ea.htm EX-32.1 8475
5 EX-32.2 rytm-20190331ex3226f2fce.htm EX-32.2 8464
  Complete submission text file 0001558370-19-003924.txt   4078761

Data Files

Seq Description Document Type Size
6 EX-101.INS rytm-20190331.xml EX-101.INS 636030
7 EX-101.SCH rytm-20190331.xsd EX-101.SCH 26089
8 EX-101.CAL rytm-20190331_cal.xml EX-101.CAL 34357
9 EX-101.DEF rytm-20190331_def.xml EX-101.DEF 64271
10 EX-101.LAB rytm-20190331_lab.xml EX-101.LAB 236232
11 EX-101.PRE rytm-20190331_pre.xml EX-101.PRE 175022
Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 19794452
SIC: 2834 Pharmaceutical Preparations